IP Library Granted Patent US 10,179,098
Granted Patent B2
US 10,179,098 · App. 15/674,034 · Granted Jan 15, 2019

Oral care compositions

Inventors: Aarti Rege (East Windsor, NJ); Michael Prencipe (West Windsor, NJ); Marc Estriplet (Scotch Plains, NJ)
Assignee: Colgate-Palmolive Company
A61K8/44A61K8/21A61K8/24A61K8/27A61K8/362A61K8/365A61Q11/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,179,098
App. No.
15/674,034
Granted
Jan 15, 2019
Kind
B2
Abstract

An oral care composition comprising zinc phosphate, stannous fluoride, arginine or lysine and an organic acid buffer system, as well as methods of using the same.

Claims (22)

1. A high water oral care composition comprising

an orally acceptable carrier comprising from 10% to 90% water,

from 0.05 to 10% by weight zinc phosphate,

from 0.01% to 5% by weight stannous fluoride,

from 0.1% to 6% by weight arginine or lysine, and

from 0.1 to 5.0% by weight of an organic acid buffer system selected from citric acid, lactic acid, malic acid, maleic acid, fumaric acid, acetic acid, succinic acid, and tartaric acid, measured as the combined amount of organic acid and any conjugate base salt;

wherein all amounts are based upon the total weight of the composition.

2. A composition according to claim 1 , wherein the zinc phosphate is a preformed salt of zinc phosphate.

3. A composition according to claim 1 , wherein the amount of the water is 10% by weight or more, relative to the weight of the oral care composition.

4. A composition according claim 1 , wherein the organic buffer system comprises a carboxylic acid and one or more conjugate base salts thereof, for example, alkali metal salts thereof.

5. A composition according to claim 4 , wherein the one or more conjugate base salts are independently selected from sodium and potassium salts, or combinations thereof.

6. A composition according to claim 4 , wherein the acid is citric acid, and the one or more conjugate base salts comprise monosodium citrate (monobasic), disodium citrate (dibasic), trisodium citrate (tribasic), and combinations thereof.

7. A composition according to claim 1 , wherein the buffer system comprises citric acid and a sodium citrate salt, in a ratio of from 1:3 to 1:6.

8. A composition according to claim 1 , wherein the composition comprises arginine or lysine at about 1.5% by wt.

9. A composition according to claim 1 , wherein the composition comprises arginine.

10. A composition according to claim 1 , wherein the composition comprises lysine.

11. A composition according to claim 1 , further comprising an effective amount of one or more alkali phosphate salts.

12. A composition according to claim 10 , wherein the alkali phosphate salts comprise tetrasodium pyrophosphate or tetrapotassium pyrophosphate, optionally in an amount of 0.5 to 5% by weight of the composition.

13. A composition according to claim 10 , wherein the alkali phosphate salts comprise sodium tripolyphosphate or potassium tripolyphosphate, optionally in an amount of 0.5 to 6% by weight of the composition.

14. A composition according to claim 1 , further comprising one or more sources of zinc ions in addition to the zinc phosphate, for example, a zinc salt selected from zinc citrate, zinc oxide, zinc lactate, zinc pyrophosphate, zinc sulfate, or zinc chloride.

15. A composition according to claim 1 , wherein the oral care composition is a dentifrice.

16. A method of treatment or prevention of erosive tooth demineralization, gingivitis, plaque, and/or dental caries, the method comprising the application to the oral cavity of a person in need thereof a composition according to claim 1 .

Continuity (2)
Provisional Application 62437085 · Dec 21, 2016
Related Publication 20180168977A1 · Jun 21, 2018
Cited By (2)
US 12,194,123 US 12,419,817